Fig. 6From: TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammationThe biosafety assessment of UC-MSCs therapy. a The morphological measurements of major organs, including kidneys, hearts, lungs, and spleens in liver fibrotic mice with UC-MSCs therapy were evaluated by H&E staining. Scale bar: 100 μm. b and c Kidney function was evaluated by examined the serum levels of BUN (b) and Cr (c). d and e Myocardial enzyme assays were performed by examined the serum levels of LDH (d) and CK (e). The data were presented as the mean ± SD. One-way ANOVA: #p > 0.05Back to article page